newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Joins Russell 2000® and 3000® Indices

CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium" or the "Company") (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, joins the broad-market Russel